How health care CFOs can adapt to emerging industry conditions

BY Tina Wheeler, Partner, US Health Care, Bill Laughlin, Principal, Life Sciences and Healthcare, Omosede Ogiamien, Partner, Risk and Financial Advisory, Heather Hagan, Principal, Healthcare, Maulesh Shukla, India Lead, Healthcare, & Madhushree Wagh, Senior Research Analyst, Deloitte A recent Deloitte Center for Health Solutions survey of health care finance leaders revealed that 84% are concerned about business conditions stemming from potential regulatory and policy changes, macroeconomic uncertainty, and disruptions related to tariffs and supply chains....

FDA’s priority vouchers promise benefits, but may come at a cost

BY Blinn E. Combs, Esq. and Michael R. Alexander, Esq., Brown & Fortunato, P.C.   On June 17, 2025, a little over two months after initiating large-scale layoffs at the agency, the federal Food and Drug Administration (“FDA”) announced a new Commissioner’s National Priority Voucher (“CNPV”) program. The CNPV aimed to give voucher recipients the opportunity to shorten new drug approval timelines from 10-12 months down to 1-2 months. The program aims to address four...

What are the health benefits of Tai Chi?

BY Samuel Mathis, MD   During medical school, I had the opportunity to study abroad at the International Institute for Traditional Chinese Medicine and Acupuncture in Beijing, China. During my time there, my classmates and I learned the basics of Traditional Chinese Medicine, the importance of balance in the body and health, and the fundamentals of acupuncture. When not in class, we explored the city, ate amazing food, and spent a lot of time at...

Health care should be exempted from dramatic H-1B visa fee hike

BY John Hawkins, President and CEO, THA   “Access to care” is a broad term heard a lot in our industry. Providing and improving it is always the aim, but there are many pieces to that puzzle – untold numbers of angular pieces involving patient, insurer and workforce factors. At the heart of that effort is bringing highly skilled medical professionals together with the patients who need their care. To many hospitals, H-1B worker visas...

Memorial Hermann Health System appoints Guy Giesecke, Senior Vice President and CEO, Children’s Memorial Hermann Hospital

Memorial Hermann Health System is proud to announce that Guy B. Giesecke, DHA, is appointed Senior Vice President and Chief Executive Officer of Children’s Memorial Hermann Hospital. With nearly two decades in pediatric leadership, Dr. Giesecke has significant experience leading transformative hospital growth that has expanded access to high-quality, specialized care for children and families. “We look forward to the many ways Dr. Giesecke’s leadership will help shape the future of pediatric health at Children’s...

Memorial Hermann Katy Hospital announces Major Expansion

Memorial Hermann Health System today announced a $282.5 million expansion of Memorial Hermann Katy Hospital, designed to meet the needs of the region’s rapidly growing population and the rising demand for high-quality, patient-centered care, supported by leading-edge technology. Construction is scheduled to begin in late 2026. The centerpiece of the planned expansion is a new eight-story patient tower, which will include additional inpatient beds, advanced imaging services and a rooftop helipad for Memorial Hermann Life Flight®. Additional...

Traces of bacteria inside brain tumors may affect tumor behavior

Researchers have uncovered unexpected traces of bacteria within brain tumors. The data revealed that bacterial genetic and cellular elements were present inside brain tumor cells and across the tumor microenvironment. These bacterial components appeared biologically active, potentially influencing tumor behavior and progression in patients with gliomas and brain metastases. The multi-institutional study was led by Golnaz Morad, D.D.S, Ph.D., postdoctoral research fellow in Surgical Oncology, and Jennifer Wargo, M.D., professor of Surgical Oncology and Genomic Medicine and core member of the...

Inflammation may be responsible for driving earliest stages of lung cancer

By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers discovered that the earliest stages of lung cancer may be driven by inflammation, suggesting that targeting proinflammatory pathways could be an early intervention approach. The study generated spatial transcriptomic maps in precancerous and more advanced stages of lung cancer to provide a deeper understanding of early lung cancer development. The research was led by Humam Kadara, Ph.D., professor of Translational Molecular Pathology, and Linghua...

Alzheimer’s Disease can hijack communication between brain and fat tissue, potentially worsening cardiovascular and metabolic health

A recent study from Houston Methodist sheds light on how Alzheimer’s disease may contribute to larger health issues by hijacking the body’s ability to regulate its metabolism. Researchers have discovered that along with the negative effects an Alzheimer’s diagnosis brings, the disease can also sabotage messages between nerves and blood vessels in fat tissue, which can worsen heart and metabolic conditions such as stroke, heart disease and diabetes.   The first-of-its-kind research, “Alzheimer’s disease disrupts intra-adipose neurovascular...

MJH footer logo with red letters

Medical Journal – Houston is the leading source of healthcare business news. With extremely relevant content, late-breaking news and monthly exclusives from industry experts, MJH News has created a winning combination of must-read editorial that physicians and hospital executives eagerly anticipate month after month. MJH News is the resource that provides everything they need in one place, and it is a high honor that they rely upon Medical Journal – Houston to keep their practice or hospital on the cutting edge.

Archives